May 9, 2023
There are two primary ways in which shortages are flagged for pharmacists and dispensers. The first is the granting of a concession for generic products and the second is the product’s addition to the NHS’ serious shortage protocols (SSP) list. These have both been...
Feb 7, 2023
VPAS continues to be one of the top priorities for the UK Pharma Industry. A week or so ago, we undertook some analysis on Originator Brands, assessing profitability and UK market attractiveness. If the rebate is unsustainable, and results in loss making products for...
Jan 30, 2023
Although the aim of the VPAS scheme is to support innovation and better patient outcomes, alongside keeping a lid on the NHS drug budget, could the scheme actually be doing the opposite? If the rebate is unsustainable, and results in loss making products for...
Jan 30, 2023
We’ve all read the latest from NICE on the revised recommendations for the use of Statins to reduce the risk of cardiovascular events. It’s been widely shared that there are currently 10 million eligible patients in the UK, and this could rise to as many as 25...
Dec 23, 2022
With the recent increase in bacterial infections and the shortage of Strep A antibiotic drugs such as penicillin and amoxicillin, Wavedata thought it worth looking at all the antibiotics used in the community in the UK to see which have experienced the greatest price...
Dec 12, 2022
Branded Procoralan first appeared on price lists sent to pharmacists and dispensing doctors in the UK in February 2008, followed 5 months later in July 2008 by parallel imported versions. The number of offers each month for the parallel import grew slowly to a peak of...
